Home › Treatment-Resistant Depressive Disorder › Georgia
Treatment-Resistant Depressive Disorder clinical trials in Georgia
6 studies for Treatment-Resistant Depressive Disorder are looking for participants at sites in Georgia.
Cities in Georgia
Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
- Emory Healthcare, Atlanta
Recruiting
Ages 22 to 85 · All sexes · Updated Sep 29, 2026 · NCT07594483A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
- Psych Atlanta, P.C., Marietta
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07716098Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Emory University Hospital, Atlanta
Recruiting
Ages 22 to 70 · All sexes · Updated Aug 28, 2026 · NCT06423430A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- Emory University, Atlanta
- Medical College of Georgia, Augusta University, Augusta
- Psych Atlanta, Marietta
Recruiting
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT03887715A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- CenExcel, Decatur
- CenExel, Savannah
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated May 11, 2026 · NCT06524830ALTO-207 in Adults With Treatment-resistant Depression (TRD)
- Site 7148, Albany
- Site 7146, Atlanta
- Site 7064, Peachtree Corners
- and 1 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Apr 28, 2026 · NCT07553637From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.